On the 01 st of March 2025, Gamma Interpharm proudly launched Glyclapan MR 60, a truly groundbreaking product in Sri Lanka’s healthcare sector. The grand launch ceremony marked the arrival of the first-ever Sri Lankan-manufactured Gliclazide Modified Release 60 mg tablet — with a Bioequivalence study conducted by Sri Lankans, on Sri Lankans.
What makes Glyclapan MR 60 truly special is not just its formulation, but the science behind it. We have successfully conducted a Bioequivalence study, proving its clinical reliability and aligning with international standards.
This launch reflects our ongoing commitment to quality, safety, and high efficacy. Glyclapan MR 60 is more than just a product — it’s a symbol of national pride and pharmaceutical excellence.
